Researcher
Rudi Vennekens
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Behavioural neuroscience
- Disciplines (KU Leuven):Physiology
- See also: Rudi Vennekens (Flanders Institute for Biotechnology)
Affiliations
- Department of Cellular and Molecular Medicine (Department)
Responsible
From1 Aug 2020 → Today - Voets Lab (Research group)
Member
From1 Jul 2017 → 31 Dec 2023 - Laboratory of Ion Channel Research (VIB-KU Leuven) (Division)
Member
From1 Oct 2007 → Today
Projects
1 - 10 of 23
- Development of new compounds to define the potential of TRPM4 inhibition for prevention and suppression of Ca2+ dependent cardiac arrhythmias.From1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Targeting TRP channels to relief painFrom2 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Exploring the apelinergic system in autosomal dominant polycystic kidney diseaseFrom16 Jun 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- TRP - Tackling the Roots of PainFrom1 Oct 2021 → TodayFunding: Fund Recuperation Fiscal Exemption, BOF - projects
- A kinetic, high-throughput cellular screening system (Plate Imaging Reader) for the "real time" monitoring of dynamic intracellular Ca2+ signals in living cellsFrom1 May 2020 → TodayFunding: BOF - scientific equipment program
- Ca2+ signalling in ADPKD: mechanisms and consequences.From1 Jan 2020 → 31 Dec 2023Funding: FWO research project (including WEAVE projects)
- Glucose-induced cell signaling in pancreatic ß cells during pregnancy: mechanisms of adaptation and implication for gestational diabetesFrom1 Jan 2020 → 31 Dec 2023Funding: FWO research project (including WEAVE projects)
- Analysis of Calcium signaling in autosomal dominant polycystic kidney disease.From15 Nov 2018 → 11 Feb 2022Funding: FWO fellowships
- Treatment of type 2 diabetes: from steviol glycosides to bariatric surgeryFrom1 Oct 2017 → 1 Oct 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- TRPLe - TRP channel Research Platform LeuvenFrom1 Oct 2017 → 30 Sep 2021Funding: Fund Recuperation Fiscal Exemption
Publications
1 - 10 of 115
- Leukopenia in autosomal dominant polycystic kidney disease: a single-center cohort of kidney transplant candidates with post-transplantation follow-up(2023)
Authors: Elisabet Van Loon, Maarten Coemans, Isabelle Meyts, Rudi Vennekens, Dirk Kuypers, Djalila Mekahli, Bert Bammens
Pages: 2578 - 2586 - Low agreement between various eGFR formulae in pediatric and young adult ADPKD patients(2023)
Authors: Karel Allegaert, Bert Bammens, Rudi Vennekens, Pieter Vermeersch, Hans Pottel, Djalila Mekahli
Pages: 3043 - 3053 - Apelin is altered in subjects with autosomal dominant polycystic kidney disease and preserved kidney function(2023)
Authors: Jean-Paul Decuypere, Rudi Vennekens, Bert Bammens, Djalila Mekahli
Pages: 1907 - 1911 - Exploring the role of TRPM4 in calcium-dependent triggered activity and cardiac arrhythmias(2023)
Authors: Andy Pironet, Rudi Vennekens
- Risk Severity Model for Pediatric Autosomal Dominant Polycystic Kidney Disease Using 3D Ultrasound Volumetry(2023)
Authors: Frederik De Keyzer, Rudi Vennekens, Bert Bammens, Chantal Van Ongeval, Djalila Mekahli
Pages: 581 - 591 - TRPM4 regulates hilar mossy cell loss in temporal lobe epilepsy(2023)
Authors: Rudi Vennekens
- The emerging role of the apelinergic system in kidney physiology and disease(2022)
Authors: Jean-Paul Decuypere, Bert Bammens, Rudi Vennekens, Djalila Mekahli
Pages: 2314 - 2326 - Acute inhibition of transient receptor potential vanilloid-type 4 cation channel halts cytoskeletal dynamism in microglia(2022)
Authors: Rudi Vennekens
Pages: 2157 - 2168 - PHARMACOKINETICS OF ORAL REBAUDIOSIDE A IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND ITS EFFECTS ON GLUCOSE HOMEOSTASIS: A PLACEBO-CONTROLLED CROSSOVER TRIAL(2022)
Authors: Caroline Simoens, Caroline Wuyts, Joris Van Loco, Jaak Billen, Jan de Hoon, Roman Vangoitsenhoven, Ann Mertens, Rudi Vennekens, Bart Van Der Schueren
Pages: 1 - 13 - TRPM4 inhibition by meclofenamate suppresses Ca2+-dependent triggered arrhythmias(2022)
Authors: Andy Pironet, Sara Kerselaers, Joren Verelst, Wouter Oosterlinck, Bernd Nilius, Thomas Voets, Rudi Vennekens
Pages: 4195 - +